Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.23 USD | -0.14% | +8.20% | +23.11% |
Financials (USD)
Sales 2024 * | 270M | Sales 2025 * | 120M | Capitalization | 1.66B |
---|---|---|---|---|---|
Net income 2024 * | 77M | Net income 2025 * | 68M | EV / Sales 2024 * | 4.5 x |
Net cash position 2024 * | 442M | Net cash position 2025 * | 677M | EV / Sales 2025 * | 8.17 x |
P/E ratio 2024 * |
24.5
x | P/E ratio 2025 * |
-22.3
x | Employees | 124 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98% |
Latest transcript on Protagonist Therapeutics, Inc.
1 day | -0.14% | ||
1 week | +8.20% | ||
Current month | +12.43% | ||
1 month | +4.40% | ||
3 months | -0.21% | ||
6 months | +82.25% | ||
Current year | +23.11% |
Managers | Title | Age | Since |
---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 67 | 08-11-30 |
Asif Ali
DFI | Director of Finance/CFO | 50 | 22-04-17 |
Chief Tech/Sci/R&D Officer | - | 17-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lewis Williams
BRD | Director/Board Member | 74 | 17-06-07 |
Harold Selick
CHM | Chairman | 69 | 09-01-31 |
Daniel Swisher
BRD | Director/Board Member | 61 | 23-10-25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 2 M€ | -.--% | ||
0.05% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 28.23 | -0.14% | 513,289 |
24-05-09 | 28.27 | +4.28% | 599,466 |
24-05-08 | 27.11 | +5.12% | 774,657 |
24-05-07 | 25.79 | -1.04% | 321,637 |
24-05-06 | 26.06 | -0.11% | 354,349 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.11% | 1.66B | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- PTGX Stock